PAU, Maria Carmina
 Distribuzione geografica
Continente #
NA - Nord America 373
EU - Europa 151
AS - Asia 77
OC - Oceania 2
Totale 603
Nazione #
US - Stati Uniti d'America 373
IT - Italia 72
CN - Cina 49
UA - Ucraina 47
DE - Germania 19
KR - Corea 13
SG - Singapore 4
TR - Turchia 3
AU - Australia 2
BE - Belgio 2
FI - Finlandia 2
GB - Regno Unito 2
HK - Hong Kong 2
LU - Lussemburgo 2
SE - Svezia 2
BD - Bangladesh 1
BG - Bulgaria 1
FR - Francia 1
ID - Indonesia 1
IL - Israele 1
JP - Giappone 1
MD - Moldavia 1
MY - Malesia 1
VN - Vietnam 1
Totale 603
Città #
Chandler 125
Sassari 38
New York 36
Princeton 28
Jacksonville 27
Dearborn 14
Seoul 13
Ann Arbor 10
Nanjing 9
Wilmington 8
Jinan 6
Shenyang 6
Ashburn 5
Nanchang 5
Hangzhou 4
Mountain View 4
Beijing 3
Boardman 3
Izmir 3
Jiaxing 3
Milan 3
Noicattaro 3
Quartu Sant'elena 3
Taizhou 3
Brussels 2
Changsha 2
Ningbo 2
Norwalk 2
Singapore 2
Washington 2
Zhengzhou 2
Catanzaro 1
Central 1
Da Nang 1
Dhaka 1
Edinburgh 1
Gallarate 1
Guangzhou 1
Haikou 1
Hanover 1
Houston 1
Kuala Lumpur 1
Luxembourg 1
Macomer 1
Majalengka 1
Melbourne 1
Nuoro 1
Oristano 1
Paris 1
Pomezia 1
Ragusa 1
Reston 1
Rome 1
Scandicci 1
Seattle 1
Sofia 1
Sydney 1
Tappahannock 1
Tel Aviv 1
Tianjin 1
Tokyo 1
Verdello 1
Xian 1
Totale 408
Nome #
Clinical impact of the two ART resistance markers, K13 gene mutations and DPC3 in Vietnam 87
Band 3 erythrocyte membrane protein acts as redox stress sensor leading to its phosphorylation by p72Syk 68
Syk Inhibitors interfere with erythrocyte membrane modification during P. falciparum growth and suppress parasite egress 59
Induction of high tolerance to artemisinin by sub-lethal administration: A new in vitro model of P. falciparum 53
Total antioxidant capacity in Mediterranean β-thalassemic patients 51
IN VITRO AND IN VIVO EFFECT OF SYK INHIBITORS AS A NEW ANTIMALARIAL DRUGS 44
Artemisinin resistance, some facts and opinions 40
Syk kinase inhibitors synergize with artemisinins by enhancing oxidative stress in plasmodium falciparum-parasitized erythrocytes 34
Syk inhibitors: New computational insights into their intraerythrocytic action in plasmodium falciparum malaria 28
Oxidative Stress Biomarkers in Chronic Obstructive Pulmonary Disease Exacerbations: A Systematic Review 24
Glutathione peroxidase in stable chronic obstructive pulmonary disease: A systematic review and meta-analysis 22
Circulating malondialdehyde concentrations in obstructive sleep apnea (Osa): A systematic review and meta-analysis with meta-regression 22
Clinical significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute exacerbations of COPD: present and future 14
Comparison of Clinical Features, Complete Blood Count Parameters, and Outcomes between Two Distinct Waves of COVID-19: A Monocentric Report from Italy 14
Paraoxonase-1 in stable chronic obstructive pulmonary disease: a systematic review and meta-analysis 13
Circulating superoxide dismutase concentrations in obstructive sleep apnoea (OSA): A systematic review and meta-analysis 13
A systematic review and meta-analysis of homocysteine concentrations in chronic obstructive pulmonary disease 11
Evaluation of Inflammation and Oxidative Stress Markers in Patients with Obstructive Sleep Apnea (OSA) 9
Paraoxonase-1 Concentrations in Obstructive Sleep Apnoea: A Systematic Review and Meta-Analysis 9
Vaccination Status and Number of Vaccine Doses Are Independently Associated with the PaO2/FiO2 Ratio on Admission in Hospitalized COVID-19 Patients 7
A Comprehensive Systematic Review and Meta-Analysis of the Association between the Neutrophil-to-Lymphocyte Ratio and Adverse Outcomes in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease 7
Association between Red Blood Cell Distribution Width and Obstructive Sleep Apnea Syndrome: A Systematic Review and Meta-Analysis 6
Totale 635
Categoria #
all - tutte 3.413
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.413


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201919 0 0 0 0 0 0 0 0 0 0 0 19
2019/202093 24 5 4 2 8 11 19 2 8 2 8 0
2020/202183 8 0 7 3 8 0 14 2 30 10 1 0
2021/202270 6 0 0 2 0 0 2 5 11 2 11 31
2022/2023217 17 30 5 37 10 32 1 21 43 1 17 3
2023/2024116 9 10 10 3 33 23 1 1 1 4 21 0
Totale 635